Aurora Cannabis Inc (NASDAQ: ACB)’s stock price has plunge by 10.71relation to previous closing price of 5.51. Nevertheless, the company has seen a 11.11% surge in its stock price over the last five trading sessions. zacks.com reported 2024-10-17 that ACB and MedReleaf Australia launch premium medical cannabis oils, offering tailored cannabinoid formulations for patient care.
Is It Worth Investing in Aurora Cannabis Inc (NASDAQ: ACB) Right Now?
The stock has a 36-month beta value of 1.87. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ACB is 54.43M, and at present, short sellers hold a 4.76% of that float. On October 23, 2024, the average trading volume of ACB was 1.12M shares.
ACB’s Market Performance
ACB stock saw an increase of 11.11% in the past week, with a monthly gain of 8.73% and a quarterly increase of 5.90%. The volatility ratio for the week is 4.50%, and the volatility levels for the last 30 days are 4.36% for Aurora Cannabis Inc (ACB). The simple moving average for the last 20 days is 9.86% for ACB stock, with a simple moving average of 12.64% for the last 200 days.
ACB Trading at 4.10% from the 50-Day Moving Average
After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.76% of loss for the given period.
Volatility was left at 4.36%, however, over the last 30 days, the volatility rate increased by 4.50%, as shares surge +6.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.28% lower at present.
During the last 5 trading sessions, ACB rose by +11.11%, which changed the moving average for the period of 200-days by +28.42% in comparison to the 20-day moving average, which settled at $5.55. In addition, Aurora Cannabis Inc saw 28.10% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ACB
Current profitability levels for the company are sitting at:
- -0.39 for the present operating margin
- 0.45 for the gross margin
The net margin for Aurora Cannabis Inc stands at -2.7. The total capital return value is set at -0.13. Equity return is now at value -5.70, with -3.54 for asset returns.
Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.8. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is -4.07.
Currently, EBITDA for the company is 20.47 million with net debt to EBITDA at 0.21. When we switch over and look at the enterprise to sales, we see a ratio of 1.84. The receivables turnover for the company is 5.41for trailing twelve months and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.76.
Conclusion
To sum up, Aurora Cannabis Inc (ACB) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
